Barclays’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Buy
64,821
+33,680
+108% +$628K ﹤0.01% 2541
2025
Q1
$565K Sell
31,141
-11,625
-27% -$211K ﹤0.01% 2769
2024
Q4
$933K Buy
42,766
+1,082
+3% +$23.6K ﹤0.01% 2672
2024
Q3
$1.14M Buy
41,684
+33,185
+390% +$908K ﹤0.01% 2545
2024
Q2
$220K Sell
8,499
-5,904
-41% -$153K ﹤0.01% 3000
2024
Q1
$432K Buy
14,403
+14,400
+480,000% +$432K ﹤0.01% 2919
2023
Q4
$0 Buy
+3
New ﹤0.01% 4226
2023
Q3
Sell
-3
Closed 4277
2023
Q2
$0 Hold
3
﹤0.01% 4274
2023
Q1
$0 Sell
3
-330
-99% ﹤0.01% 4322
2022
Q4
$2K Sell
333
-120
-26% -$721 ﹤0.01% 4284
2022
Q3
$10K Sell
453
-87
-16% -$1.92K ﹤0.01% 4167
2022
Q2
$10K Sell
540
-287
-35% -$5.32K ﹤0.01% 4310
2022
Q1
$38K Sell
827
-1,966
-70% -$90.3K ﹤0.01% 4106
2021
Q4
$198K Buy
2,793
+1,505
+117% +$107K ﹤0.01% 2832
2021
Q3
$151K Sell
1,288
-354
-22% -$41.5K ﹤0.01% 3090
2021
Q2
$257K Sell
1,642
-552
-25% -$86.4K ﹤0.01% 2789
2021
Q1
$415K Sell
2,194
-224
-9% -$42.4K ﹤0.01% 2752
2020
Q4
$304K Buy
2,418
+267
+12% +$33.6K ﹤0.01% 2535
2020
Q3
$233K Buy
2,151
+788
+58% +$85.4K ﹤0.01% 2659
2020
Q2
$164K Buy
1,363
+823
+152% +$99K ﹤0.01% 2904
2020
Q1
$55K Sell
540
-665
-55% -$67.7K ﹤0.01% 3058
2019
Q4
$292K Buy
1,205
+572
+90% +$139K ﹤0.01% 2989
2019
Q3
$104K Sell
633
-392
-38% -$64.4K ﹤0.01% 3382
2019
Q2
$242K Buy
1,025
+507
+98% +$120K ﹤0.01% 3100
2019
Q1
$137K Buy
518
+352
+212% +$93.1K ﹤0.01% 3191
2018
Q4
$15K Buy
166
+71
+75% +$6.42K ﹤0.01% 3454
2018
Q3
$18K Buy
+95
New +$18K ﹤0.01% 3940